< Back to previous page
Researcher
Eline Vandael
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → 30 Jun 2019
Projects
1 - 1 of 1
- Development of decision support systems to manage QT-prolongation in clinical practice.From1 Jan 2013 → 31 Dec 2016Funding: IWT personal funding - strategic basic research grants
Publications
21 - 28 of 28
- Frequency of use of QT-interval prolonging drugs in psychiatry in Belgium(2014)
Authors: Eline Vandael, Isabel Spriet, Joris Vandenberghe, Rik Willems, Veerle Foulon
Pages: 757 - 65 - Waakzaam met ontstekingswerende medicatie(2014)
Authors: Laura-Lynn Thoeng, Marina Lermytte, Katrien Bosseloo, Eline Vandael, Gert Laekeman
Pages: 19 - 21 - Attention aux anti-inflammatoires(2014)
Authors: Laura-Lynn Thoeng, Marina Lermytte, Katrien Bosseloo, Eline Vandael, Gert Laekeman
Pages: 19 - 21 - Impact of training on pharmacists’ counseling of patients starting antidepressant therapy(2014)
Authors: Sophie Liekens, Eline Vandael, Tim Smits, Gert Laekeman, Veerle Foulon
Pages: 110 - 115 - Risk management of QT-prolongation in a Belgian university hospital: epidemiological data(2014)
Authors: Eline Vandael, Bert Vandenberk, Joris Vandenberghe, Isabel Spriet, Rik Willems, Veerle Foulon
Pages: 183 - 183 - Antidepressiva en het risico van QT-verlenging(2013)
Authors: Eline Vandael, Gert Laekeman, Veerle Foulon
Pages: 34 - 40 - Prevalence of QT-prolongation in psychiatric hospitals in Belgium(2013)
Authors: Eline Vandael, Johan Reyntens, Rik Willems, Joris Vandenberghe, Isabel Spriet, Veerle Foulon
Pages: 1265 - 1266 - Development of decision support systems to manage QT-prolongation in clinical practice: study protocol(2013)
Authors: Eline Vandael, Rik Willems, Joris Vandenberghe, Veerle Foulon
Pages: 490 - 490